Miragen Therapeutics, Inc. Gains 20.71%
Thu, Jan 30, 2020 at 05:30 PM
Miragen Therapeutics, Inc. (MGEN:NASDAQ) rocketted at $2.04, a gain of 20.7%. On Wed 29 Jan 20, MGEN:NASDAQ touched a New 2-Week High of $1.69. The stock got featured on our News Catalysts scanner on Thu 30 Jan 20 at 08:07 AM in the 'BIOTECH' category. From Wed 08 Jan 20, the stock recorded 64.29% Up Days and 66.67% Green Days
About Miragen Therapeutics, Inc. (MGEN:NASDAQ)
Miragen Therapeutics Inc is a clinical-stage biopharmaceutical company which engaged in discovering and developing proprietary RNA (Ribonucleic acid)-targeted therapeutics.
Top 10 Gainers:
- Cleveland BioLabs, Inc. (CBLI:NASDAQ), 41.26%
- Sintx Technologies, Inc. (SINT:NASDAQ), 41.1%
- Advaxis, Inc. (ADXS:NASDAQ), 33.54%
- Universal Security Instruments, Inc. (UUU:NYSEMKT), 29.65%
- Allied Healthcare Products, Inc. (AHPI:NASDAQ), 27.56%
- NanoViricides, Inc. (NNVC:NYSEMKT), 26.58%
- ReTo Eco-Solutions, Inc. (RETO:NASDAQ), 20.87%
- Lianluo Smart Limited (LLIT:NASDAQ), 20.83%
- Miragen Therapeutics, Inc. (MGEN:NASDAQ), 20.71%
- Hancock Jaffe Laboratories, Inc. (HJLI:NASDAQ), 20.4%